Enzalutamide
SHARE
Molecule Summary
| Uses | Prostate cancer |
| Therapy | Anti-Neoplastic |
| Side Effects | Fatigue, back pain, diarrhoea, weakness, dizziness, headache |
Medicines
available
19k pincodes
Molecule Description
Enzalutamide is used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) that has progressed on or after docetaxel therapy. It works by blocking the effects of hormones, leading to the death of cancer cells. The doctor determines the dose and duration of this treatment. Before starting, inform your doctor if you have diabetes, seizures, liver or kidney issues, or if you are taking any medications for infections. Other medicines can affect or be affected by this medication, so inform your doctor about all your medications. This medicine is not recommended during pregnancy or while breastfeeding. It is vital for both males and females to use effective contraception during treatment to prevent pregnancy. You may be required to undergo regular monitoring of blood glucose levels while receiving treatment.
Uses
- For the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed on or after Docetaxel therapy.
Contraindications
When should one not use Enzalutamide
- Known allergy to any ingredients of this medicine
- If you are pregnant or may become pregnant
Side effects
Common side effects of this drug are:
- Fatigue
- Back pain
- Diarrhoea
- Weakness
- Dizziness
- Headache
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
Talk to your doctor if
- You have abnormal kidney, liver and heart function
- You have a clotting disorder
- You have cancer and/or undergoing chemotherapy
- You are taking Warfarin/Anticoagulant therapy
Mode of Action
How Does It Work?
Enzalutamide acts by inhibiting the function of androgens (hormones like testosterone). Enzalutamide inhibits the growth and division of prostate cancer cells by inhibiting androgens.
Interactions
Interactions with other medicines
- CYP2C8 inhibitors like gemfibrozil increases the concentration of Enzalutamide
- CYP3A4 inhibitor itraconazole increases the action of Enzalutamide
- CYP2C8 and strong CYP3A4 inducer rifampin decreases effect of Enzalutamide
- Enzalutamide decreases the synthesis of midazolam, warfarin, and Omeprazole
- Simultaneous use of Enzalutamide with quinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide, antiarrhythmic medicinal products, methadone, moxifloxacin, antipsychotics can prolong the QT interval (Abnormal heart rhythm disorder with chaotic heart beats)
Dosage
Overdose
Visit a doctor or the nearest hospital immediately, in case of an overdose.
Missed a Dose
In case of a missed dose, take next dose at scheduled time. Do not take more doses than recommended.
Frequently Asked Questions (FAQs)
Articles
View AllDid you find this helpful?
References:
Explore More at Pharmeasy
Why trust PharmEasy?
# ONE OF INDIA'S MOST TRUSTED HEALTHCARE PLATFORM
CODAvailable
100%Genuine Medicine
30 DAYReturn Policy









